ENTITY

Rain Oncology (RAIN US)

4
Analysis
Health CareUnited States
Rain Oncology Inc. operates as a clinical stage biotechnology company. The Company develops and produces biomarker-driven small molecule therapeutics for patients with cancer and other related diseases. Rain Oncology serves customers worldwide.
more
bearishRain Oncology
27 Oct 2025 04:08Primer

Primer: Rain Oncology (RAIN US) - Oct 2025

Company Acquired: Rain Oncology was acquired by Pathos AI, Inc. and ceased to trade as an independent public entity in January 2024. This...

Logo
αSK
378 Views
Share
bullishFuel Tech
16 Sep 2025 21:58Issuer-paid

Sustainable Investing Surveyor Focus on Fuel Tech

Last week, the WTR Sustainable Index was up 2.1% W/W versus the S&P 500 Index (up 1.6%), the Russell 2000 Index (up 0.3%), and the Nasdaq Index (up...

Logo
212 Views
Share
09 Sep 2025 20:16Issuer-paid

Sustainable Investing Surveyor Focus on Eco Wave Power (WAVE) - September 8, 2025

Last week, the WTR Sustainable Index was down 0.4% W/W versus the S&P 500 Index (up 0.3%), the Russell 2000 Index (up 1.0%), and the Nasdaq Index...

Logo
172 Views
Share
bearishRain Oncology
15 Dec 2023 07:15Syndicated

Closing RAIN

Rain Oncology (RAIN) is being bought out for $1.16 + CVR worth up to $0.17/share. This seems like a worse deal than the $1.25 + CVR Tang was...

Share
x